Evidence map›Paper›PMID 39008673›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Tetsuya Miyamoto, Sheida Hedjazi, Chika Miyamoto, Hubert Amrein

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Frontiers in endocrinology · 2026
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

4 authors.

Tetsuya MiyamotoDepartment of Cell Biology and Genetics, School of Medicine, Texas A&M University, Bryan, TX 77807.ORCID 0000-0001-5108-4521
Sheida HedjaziDepartment of Cell Biology and Genetics, School of Medicine, Texas A&M University, Bryan, TX 77807.
Chika MiyamotoDepartment of Cell Biology and Genetics, School of Medicine, Texas A&M University, Bryan, TX 77807.
Hubert AmreinDepartment of Cell Biology and Genetics, School of Medicine, Texas A&M University, Bryan, TX 77807.ORCID 0000-0001-8799-7250

Funding

The taste of ribonucleosides: The molecular and cellular basis underlying chemosensory detection of previously unknown macronutrientsR01DC018403 · NIDCD · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI AMREIN, HUBERT O · 2020 to 2024
$1.9M
Modulation of peptidergic neurons by the gluconeogenic enzyme Glucose-6-PhosphataseR21NS118118 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI AMREIN, HUBERT O · 2020 to 2020
$409k
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) 1R21NS118118-01NIDCD NIH HHS R01 DC018403NINDS NIH HHS R21 NS118118
6 · The paper itself

Abstract

Neuropeptides (NPs) and their cognate receptors are critical effectors of diverse physiological processes and behaviors. We recently reported of a noncanonical function of the

Indexed as

Drosophila melanogasterFMRFamideGlucose-6-PhosphataseGlycogenNeuronsNeuropeptidesSignal TransductionAnimalsDrosophila ProteinsGlucoseGolgi ApparatusHomeostasisMusclesDrosophila ProteinsFMRFamideGlucoseGlucose-6-PhosphataseGlycogenNeuropeptidesDrosophilaFMRFamideglucose-6-phosphataseglycogenneuropeptide

Identifiers

PMID39008673
PMCPMC11287260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.